Mizuho Securities analyst Anthony Petrone has maintained their neutral stance on ISRG stock, giving a Hold rating on October 7.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Anthony Petrone has given his Hold rating due to a combination of factors influencing Intuitive Surgical’s current market position. Despite the company exceeding expectations with higher procedure volumes and improved systems revenue, there are underlying concerns that temper the outlook. The company’s ability to place more systems and increase utilization has been positive, but potential challenges such as competition from refurbished instruments and accessories, as well as shifts in US capital spending due to Medicaid and ACA funding uncertainties, present hurdles.
Moreover, while Intuitive Surgical has shown resilience in maintaining its growth status, the evolving competitive landscape and potential tariff impacts could limit further upside. The recent gains in share price may hold, but the potential for significant growth is capped until further catalysts, such as tariff resolutions and competitive dynamics, are addressed. As a result, Petrone maintains a cautious stance with a Hold rating, reflecting a balanced view of the company’s strengths and the challenges it faces.
According to TipRanks, Petrone is a 4-star analyst with an average return of 5.1% and a 48.46% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Haemonetics, Intuitive Surgical, and Teleflex.
In another report released on October 7, Evercore ISI also maintained a Hold rating on the stock with a $450.00 price target.